Vidaza® for the treatment of all five subtypes of Myelodysplastic Syndromes (MDS) these subtypes include: refractory anemia or refractory anemia with ringed sideroblasts (RARS) (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).
No comments:
Post a Comment